| Fairview Orthotics & Prosthetics | |
| 2200 University Ave W, Ste 114, Saint Paul, Minnesota 55114 | |
| (651) 644-5808 |
| Name | Fairview Orthotics & Prosthetics |
|---|---|
| Organization Name | Fairview Health Services |
| Location | 2200 University Ave W, Ste 114, Saint Paul, Minnesota 55114 |
| Type | Prosthetic/Orthotic Supplier |
| Phone | (651) 644-5808 |
| Participate in Medicare | Medicare enrolled and may accept medicare assignment. Please check with the supplier if they accept medicare-approved amount before you get your prescription drugs, equipment or supplies from this supplier. |
News Archive
The bacterium, called Pseudomonas aeruginosa, is the most common cause of persistent and fatal lung infections in cystic fibrosis patients. Scientists at Liverpool identified a particularly virulent strain of the bacteria that is transmissible between patients. The Liverpool Epidemic Strain (LES), referred to as a cystic fibrosis 'superbug', can cause aggressive infection and results in progressive lung decline.
For the first time, scientists have found that bacteria can use a Sonar-like system to spot other cells (either normal body cells or other bacteria) and target them for destruction.
MedCath Corporation announced today the completion of the sale of substantially all the assets of TexSan Heart Hospital, owned by MedCath and its physician investors, to Methodist Healthcare System of San Antonio. The transaction, which was announced in November, and was subject to customary closing conditions and regulatory requirements, was completed effective December 31, 2010.
PDL BioPharma, Inc. today announced that it has entered into a revenue interest assignment agreement (the "Agreement") in which it has agreed to provide ARIAD Pharmaceuticals, Inc. with up to $200 million in revenue interest financing in exchange for royalties on the net revenues of Iclusig (ponatinib).
› Verified 5 days ago
| NPI Number | 1932228632 |
| Type | Prosthetic/Orthotic Supplier |
| Address | 2200 University Ave W, Suite #114, Saint Paul, MN 55114 |
| Phone Number | 651-644-5808 |
News Archive
The bacterium, called Pseudomonas aeruginosa, is the most common cause of persistent and fatal lung infections in cystic fibrosis patients. Scientists at Liverpool identified a particularly virulent strain of the bacteria that is transmissible between patients. The Liverpool Epidemic Strain (LES), referred to as a cystic fibrosis 'superbug', can cause aggressive infection and results in progressive lung decline.
For the first time, scientists have found that bacteria can use a Sonar-like system to spot other cells (either normal body cells or other bacteria) and target them for destruction.
MedCath Corporation announced today the completion of the sale of substantially all the assets of TexSan Heart Hospital, owned by MedCath and its physician investors, to Methodist Healthcare System of San Antonio. The transaction, which was announced in November, and was subject to customary closing conditions and regulatory requirements, was completed effective December 31, 2010.
PDL BioPharma, Inc. today announced that it has entered into a revenue interest assignment agreement (the "Agreement") in which it has agreed to provide ARIAD Pharmaceuticals, Inc. with up to $200 million in revenue interest financing in exchange for royalties on the net revenues of Iclusig (ponatinib).
› Verified 5 days ago
News Archive
The bacterium, called Pseudomonas aeruginosa, is the most common cause of persistent and fatal lung infections in cystic fibrosis patients. Scientists at Liverpool identified a particularly virulent strain of the bacteria that is transmissible between patients. The Liverpool Epidemic Strain (LES), referred to as a cystic fibrosis 'superbug', can cause aggressive infection and results in progressive lung decline.
For the first time, scientists have found that bacteria can use a Sonar-like system to spot other cells (either normal body cells or other bacteria) and target them for destruction.
MedCath Corporation announced today the completion of the sale of substantially all the assets of TexSan Heart Hospital, owned by MedCath and its physician investors, to Methodist Healthcare System of San Antonio. The transaction, which was announced in November, and was subject to customary closing conditions and regulatory requirements, was completed effective December 31, 2010.
PDL BioPharma, Inc. today announced that it has entered into a revenue interest assignment agreement (the "Agreement") in which it has agreed to provide ARIAD Pharmaceuticals, Inc. with up to $200 million in revenue interest financing in exchange for royalties on the net revenues of Iclusig (ponatinib).
› Verified 5 days ago
Novacare Prosthetics & Orthotics Type: Prosthetic/Orthotic Supplier Location: 2032 Marshall Ave, Saint Paul, Minnesota 55104 Phone: (651) 645-9481 | |
Advanced Respiratory Inc Type: Durable Medical Equipment & Medical Supplies Supplier Location: 1020 West County Road F, Saint Paul, Minnesota 55126 Phone: (800) 426-4224 | |
Lloyds Pharmacy Type: Durable Medical Equipment & Medical Supplies Supplier Location: 720 Snelling N Ave, Saint Paul, Minnesota 55104 Phone: (651) 645-8636 | |
Allina Health Bandana Square Clinic Type: Medicare Supplier Location: 1021 Bandana Blvd E, Saint Paul, Minnesota 55108 Phone: (651) 241-9700 | |
Allina Health System Type: Durable Medical Equipment & Medical Supplies Supplier Location: 1055 Westgate Dr, Saint Paul, Minnesota 55114 Phone: (651) 628-4800 |